Cost-effectiveness analysis of vonoprazan versus proton pump inhibitors in the treatment of reflux esophagitis in China. [PDF]
Wang Z +5 more
europepmc +1 more source
Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD. [PDF]
Fukunaga S +4 more
europepmc +1 more source
Trends in proton pump inhibitor use, reflux esophagitis, and various upper gastrointestinal symptoms from 2010 to 2019 in Japan. [PDF]
Yamamichi N +6 more
europepmc +1 more source
Britannilactone 1-O-acetate induced ubiquitination of NLRP3 inflammasome through TRIM31 as a protective mechanism against reflux esophagitis-induced esophageal injury. [PDF]
Liu J +7 more
europepmc +1 more source
Role of Semisulcospira gottschei extract as medicinal food on reflux esophagitis in rats. [PDF]
Nam HH +5 more
europepmc +1 more source
Immunoglobulin G-mediated food intolerance and metabolic syndrome influence the occurrence of reflux esophagitis in Helicobacter pylori-infected patients. [PDF]
Wang LH +7 more
europepmc +1 more source
Esophagitis histological criteria and sensitivity reappraisal of the ambulatorial 24-hour pHmetry in gastroesophageal reflux patients [PDF]
R Flora-Filho +2 more
openalex
IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis [PDF]
Dulciene Maria Magalhães Queiroz +8 more
openalex +1 more source

